对牙周病的益生菌补充 - 一个雨审查
Hunny Sharma1, Manisha Ruikar1, Swati Verma2
1Department of Community and Family Medicine, All India Institute of Medical Sciences Raipur, Chhattisgarh, India.
概括
益生菌补充剂通过改善探针和口袋深度的出血来改善牙周病的管理. 虽然它们不是传统护理的替代品,但它们与标准治疗一起提供了潜在的好处.
科学领域:
- 口腔健康 口腔健康
- 微生物学 微生物学
- 牙周病学 牙周病学
背景情况:
- 牙周病是一种常见的炎症状况,是细菌斑块积累造成的.
- 目前正在探索益生菌补充作为治疗牙周病的辅助疗法.
研究的目的:
- 对有关益生菌在治疗牙周疾病中的有效性进行系统性审查和元分析进行总体审查.
- 总结有关在牙周治疗中使用益生菌的发现和建议.
主要方法:
- 在MEDLINE,Embase,Cochrane Central和谷歌学者中进行了系统的文献搜索.
- 包括的研究是过去十年出版的系统审查和元分析,使用AMSTAR-2工具进行评估.
主要成果:
- 益生菌在减少探针出血 (BOP),探针口袋深度 (PPD) 和改善临床附着水平 (CAL) 中显示出潜在的益处.
- 关于益生菌在减少牙炎症 (GI) 和牙斑的有效性方面的证据仍然是混合的.
- 需要进一步的研究来阐明益生菌机制和更广泛的健康益处.
结论:
- 益生菌可能为牙周病管理提供辅助益处,特别是对于BOP,PPD和CAL.
- 益生菌疗法应该补充,而不是取代,传统的牙周治疗,如缩放,根平,和勤奋的口腔卫生.
相关概念视频
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
351
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
351
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
356
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
356